SAB Biotherapeutics (SABS) EBT Margin (2021 - 2024)
SAB Biotherapeutics (SABS) reported EBT Margin of -8669.15% for Q4 2024, down 1175.40 percentage points from -7493.75% a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) EBT Margin (2021 - 2024) Analysis & Trends
For FY2024, SAB Biotherapeutics posted EBT Margin of -3171.70%, down 1287.20 percentage points from FY2023.
- EBT Margin has declined for four consecutive years, with a four-year change of -3208.12 percentage points (FY2020 to FY2024).
- By year, EBT Margin came in at -1884.50% in FY2023 (-1806.21 pp), -78.29% in FY2022 (-50.13 pp), -28.16% in FY2021 (-64.58 pp) and 36.41% in FY2020.
- The Q4 2024 figure ranks as the lowest quarterly EBT Margin in data going back to Q1 2021.
- Year over year, EBT Margin gained in two of the last seven quarters, with an average year-over-year change of -1680.52 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2024 (a gain of 5258.43 percentage points); the low point was Q2 2023 (a drop of 7969.47 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -8,669.15% |
| Jun 30, 2024 | -2,787.69% |
| Mar 31, 2024 | -532.06% |
| Dec 31, 2023 | -7,493.75% |
| Sep 30, 2023 | -402.59% |
| Jun 30, 2023 | -8,046.13% |
| Mar 31, 2023 | -1,265.50% |
| Dec 31, 2022 | -363.23% |
| Sep 30, 2022 | -197.12% |
| Jun 30, 2022 | -76.66% |
| Mar 31, 2022 | 9.13% |
| Dec 31, 2021 | -104.46% |
| Sep 30, 2021 | -27.66% |
| Jun 30, 2021 | -16.15% |
| Mar 31, 2021 | 8.33% |
API Access
SAB Biotherapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();